...
首页> 外文期刊>PLoS Medicine >Polymorphisms, Mutations, and Amplification of the EGFR Gene in Non-Small Cell Lung Cancers
【24h】

Polymorphisms, Mutations, and Amplification of the EGFR Gene in Non-Small Cell Lung Cancers

机译:非小细胞肺癌中EGFR基因的多态性,突变和扩增

获取原文
           

摘要

Background The epidermal growth factor receptor (EGFR) gene is the prototype member of the type I receptor tyrosine kinase (TK) family and plays a pivotal role in cell proliferation and differentiation. There are three well described polymorphisms that are associated with increased protein production in experimental systems: a polymorphic dinucleotide repeat (CA simple sequence repeat 1 [CA-SSR1]) in intron one (lower number of repeats) and two single nucleotide polymorphisms (SNPs) in the promoter region, ?216 (G/T or T/T) and ?191 (C/A or A/A). The objective of this study was to examine distributions of these three polymorphisms and their relationships to each other and to EGFR gene mutations and allelic imbalance (AI) in non-small cell lung cancers.
机译:背景技术表皮生长因子受体(EGFR)基因是I型受体酪氨酸激酶(TK)家族的原型成员,在细胞增殖和分化中起着关键作用。实验系统中存在三种与蛋白质生产增加有关的多态性:内含子一的多态性二核苷酸重复序列(CA单序列重复序列1 [CA-SSR1])(重复次数较少)和两个单核苷酸多态性(SNP)。在启动子区域中,λ216(G / T或T / T)和λ191(C / A或A / A)。这项研究的目的是检查这三种多态性的分布及其相互之间的关系以及与非小细胞肺癌中EGFR基因突变和等位基因失衡(AI)的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号